Options
CRISPR/Cas9-facilitated engineering with growth-coupled and sensor-guided in vivo screening of enzyme variants for a more efficient chorismate pathway in E. coli
Citation Link: https://doi.org/10.15480/882.2289
Publikationstyp
Journal Article
Date Issued
2019-12
Sprache
English
Author(s)
Institut
TORE-DOI
TORE-URI
Volume
9
Start Page
Art.-Nr. e00094
Citation
Metabolic Engineering Communications (9): e00094 (2019-12)
Publisher DOI
Scopus ID
Protein engineering plays an increasingly important role in developing new and optimizing existing metabolic pathways for biosynthesis. Conventional screening approach of libraries of gene and enzyme variants is often done using a host strain under conditions not relevant to the cultivation or intracellular conditions of the later production strain. This does not necessarily result in the identification of the best enzyme variant for in vivo use in the production strain. In this work, we propose a method which integrates CRISPR/Cas9-facilitated engineering of the target gene(s)with growth-coupled and sensor-guided in vivo screening (CGSS)for protein engineering and pathway optimization. The efficiency of the method is demonstrated for engineering 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP)synthase AroG, a key enzyme in the chorismate pathway for the synthesis of aromatic amino acids (AAAs), to obtain variants of AroG (AroG fbr )with increased resistance to feedback inhibition of Phe. Starting from a tryptophan (Trp)-producing E. coli strain (harboring a reported Phe-resistant AroG variant AroG S180F ), the removal of all the endogenous DAHP synthases makes the growth of this strain dependent on the activity of an introduced AroG variant. The different catalytic efficiencies of AroG variants lead to different intracellular concentration of Trp which is sensed by a Trp biosensor (TnaC-eGFP). Using the growth rate and the signal strength of the biosensor as criteria, we successfully identified several novel Phe-resistant AroG variants (including the best one AroG D6G−D7A )which exhibited higher specific enzyme activity than that of the reference variant AroG S180F at the presence of 40 mM Phe. The replacement of AroG S180F with the newly identified AroG D6G−D7A in the Trp-producing strain significantly improved the Trp production by 38.5% (24.03 ± 1.02 g/L at 36 h)in a simple fed-batch fermentation.
Subjects
CRISPR/Cas9
Protein engineering
Trp biosensor
DAHP synthase
Feedback inhibition
DDC Class
500: Naturwissenschaften
Loading...
Name
1-s2.0-S2214030119300045-main.pdf
Size
1.41 MB
Format
Adobe PDF